versión On-line ISSN 2078-5135
versión impresa ISSN 0256-9574
SAMJ, S. Afr. med. j. vol.102 no.5 Cape Town may. 2012
To the Editor: The radiation oncology community in South Africa can no longer support the continuation of neutron therapy. The lack of new phase III data to support this treatment modality and the fact that patients numbers never really materialised resulted in very inefficient utilisation of available resources that could have been better spent. Progress in clinical and radiation oncology during the past 20 years with new technologies readily available in this country resulted in even fewer reasons to continue this programme. The logistics involved in trying to utilise this as a national resource -which would be the same if one were to try and argue for this to be used as a resource for the continent of Africa - would result in even less benefit to society as a whole.
South Africa can no longer afford to fund such programmes given the many competing priorities in oncology and health in general. To do so would border on being socially irresponsible.
Chairman of the South African Society of Clinical and Radiation Oncology
Robbie De Muellenaere